Skip to content

The Correlations Between Fluctuations in Anxiety Symptoms and Heart Rate Variability in Patients With Panic Disorder Combined With Agoraphobia: Application of Time Series Analysis in Individual Treatment

The Correlations Between Fluctuations in Anxiety Symptoms and Heart Rate Variability in Patients With Panic Disorder Combined With Agoraphobia: Application of Time Series Analysis in Individual Treatment - Fluctuations in Agoraphobia

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37166
Enrollment
3
Registered
2012-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

agoraphobia fear of open spaces

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diagnosed with a panic disorder combined with agoraphobia as described in DSM-IV. - Women between 18 and 50 years. - Patients must be willing and capable to keep a diary and wear an accelerometer during their treatment. - Patients must be willing and capable to wear an ECG device 24 hours a day for two separate weeks

Exclusion criteria

Exclusion criteria: - Somatic and/or neurological disorders that restrict physical activity - Patiënts that are diagnosed with psychiatric comorbidity - Pregnancy - Pacemaker, medication that influence the ECG

Design outcomes

Primary

MeasureTime frame
With regular time intervals, patients will be asked to fill out a ranking scale on the following subjects in their diary; - Anxiety - Self-esteem - The frequency of panic attacks and exposure (will only be asked at the end of the day) - With whom the patients were - Where they were - Stressful events (if applicable) The physical activity and heart activity will be recorded by an accelerometer and an ambulatory ECG device. The ECG device should be carried 24h a day for two week in total: one week before and one week after the treatment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)